U.S. reg­u­la­tors ap­prove pill to track pa­tients

Truro Daily News - - World -

WASH­ING­TON — U.S. reg­u­la­tors have ap­proved the first drug with a sen­sor that can track whether pa­tients have taken their medicine.

The Abil­ify pill was first ap­proved by the Food and Drug Ad­min­is­tra­tion in 2002 to treat schizophre­nia, and the sen­sor tech­nol­ogy was ap­proved for mar­ket­ing in 2012. The FDA said in a state­ment Mon­day that the dig­i­tally-en­hanced med­i­ca­tion “works by send­ing a message from the pill’s sen­sor to a wear­able patch.” Abil­ify MyCite was de­vel­oped by Ot­suka Phar­ma­ceu­ti­cal Co. and the sen­sor was cre­ated by Pro­teus Dig­i­tal Health. While the sys­tem can track doses, it hasn’t been shown to im­prove pa­tient com­pli­ance, the FDA said.

Pa­tients can track their dosage on their smart­phone and al­low their doc­tors or care­givers to ac­cess the in­for­ma­tion through a web­site.

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.